News & Press Releases

Mintz advised Synlogic, Inc. in its definitive merger agreement with Caldera Therapeutics, Inc. in an all-stock transaction pursuant to which both companies will become wholly owned subsidiaries of a newly formed company that will operate as Caldera Therapeutics, Inc. The transaction is supported by an upsized $278 million concurrent private placement financing from a syndicate of new and existing investors and is expected to close concurrently with the completion of the merger.

Theresa Carnegie was quoted in a Corporate Counsel article discussing the FTC's settlement with CVS Caremark, the agency's evolving approach to pharmacy benefit manager regulation, and what it could mean for the industry's future.

Mintz advised the placement agents in connection with the $39 Million private placement that is expected to close in connection with the completion of the merger transaction between Scancell Holdings plc and Neuphoria Therapeutics Inc. The private placement is part of up to $89 million of financing expected to be raised by Scancell in connection with the merger transaction through a combination of equity and debt.

Michelle Capezza was quoted in a Fiduciary News article discussing the role of automatic enrollment and escalation features in retirement plans and the impact of the SECURE 2.0 Act on plan design.

Nicholas Gravante Jr. was profiled in Lawdragon's Lawyer Limelight series, reflecting on his four-decade litigation career, the mentors who influenced his development as a trial lawyer, and his decision to join Mintz earlier this year with a team of longtime colleagues.

Mintz was shortlisted in seven categories for the 2026 LMG Life Sciences Americas Awards, including firmwide recognitions for Financial & Corporate Firm of the Year and Patent Strategy Firm of the Year. Several Mintz attorneys were also shortlisted for individual honors across corporate, patent strategy, litigation, and licensing categories.